The skinny on ICD leads
This article was originally published in The Gray Sheet
St. Jude received FDA approval for its Riata ST lead, firm announces April 10. At 6.3 Fr, Riata ST makes navigation through the vasculature easier for the physician, facilitating more precise lead placement and more effective implantable cardioverter defibrillator therapy, the firm claims. Riata ST also boasts an innovative coil design to prevent tissue in-growth and ease device explantation. St. Jude launches the new lead in the U.S. April 17...
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
COVID-19: Medtronic Shares Ventilator Specs Amid Multi-Industry Efforts To Increase Ventilator Production
Medtronic shares an open-source design for its ventilator to help mitigate the nation’s ventilator shortage for COVID-19 patients.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.